| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.04 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |